continuous manufacturing: technologies and continuous manufacturing: technologies and economic...
TRANSCRIPT
Continuous Manufacturing: Technologies and Economic Benefit
2nd Symposium on Continuous Flow Reactor Technology for
Industrial Applications Oct. 4, 2010, Paris
Dr. B. Schenkel
Novartis Pharma AG:
Chemical Manufacturing of API’s in 800 stirred vessels with a total volume of 3000 m3 in batch mode. Why?
• Copy of lab
• Flexibility in production capacity (number of batches)
• Flexibility to combine reaction with distillation and extraction
• Broad ranges of reaction parameter possible, e.g. exothermic reactions can be safely run in semibatch mode
2 initiatives in Novartis to challenge the situation
and to shift to conti. manufacturing:
•Technology Platfom Conti. Manufacturing of API
• MIT/Novartis Project for Conti. Manufacturing
API manufacturing in Pharmaceutical Industry
2 | Oct. 4, 2010
Continuous Manufacturing (CM): Which Equipment is available in Chemical Development of Novartis
Installed are Microreactor/Flow reactor Units in different scale,
different labs for Early Phase Supply and Development of Production
Processes
We are planning to implement in 2011
a multipurpose Pilot Plant CM
under GMP, production capacity
of 50 kg ... 15 t/a.
15 g/
10 h
MIT
Unit
150 g/
10 h
1.5 kg/
10 h
30 kg/
10 h
Early Phase
Development
Units
Process
Development
Units
Pilot
Plant CM
(planned)
-30
°C
...
+20
0 °
C
0 b
ar
..
1
0 b
ar
(40 b
ar)
3 | Oct. 4, 2010
Continuous Manufacturing (CM): Which Equipment is available in Novartis
Syringe
pumps
and micro
gear
pumps
Feed solutions
Autosampler
Different
types of
Micro-
reactors
Standardized Flow Reactor Units
in the labs:
- Flexible equipment, design and
size
- Standardized control system
4 | Oct. 4, 2010
Successful Examples in Flow Lab: TEMPO Oxidation
R
NH
PG
OH
+ TEMPO + TBAB
NaOCl + NaHCO3
Quench
Na2S2O3
R
NH
PG
O
H Product
Starting Material (red)
Side Products (green)
Product
Starting Material
Side Products
Micro-
reactorMicro-
reactor
5 | Oct. 4, 2010
Batch
Improved
selectivity
because of
reduced over-
oxidation to
acid
Micro
reactor
Successful Examples in Flow Lab:Nitro Michael Addition
Highly energetic Nitroethylene used in Nitro Michael Addition step of a new API synthesis
CM is enabling the new synthesis: continuous Nitroethylene production and consumption
Successful process development in flow reactors of different scale:
Reaction time: 60 min
MIT microreactor/ ETFE tube 0,5mm x 100 m / static mixer 5mm x 5..20 m, Bo>300: identical
yield and enantioselectivity as in batch, robust and safe continuous process
R
H
O
H
O
R
N+
O
O
N+ O
O +Toluene
Organ. Cat. , acetic acid
Tube and Static
Mixer Reactors in lab
scale
6 | Oct. 4, 2010
Li
Mg Cl
Ar
O
N
OBoc
NH
Boc
+3
Li + . LiClAr Br Ar Mg -
( )n
( )n
Successful Examples in Flow Lab:Coupling of Grignard-like Reagent
Consecutive (over reaction) and parallel formation of byproducts can be reduced in conti. mode by adding simultaneously the starting materials into the coupling reaction. Optimal concentration profiles achieved which are not possible in batch
Yield can be increased by 6% compared to batch
Significant reduction of raw material costs in production
Cost savings justify to switch the current batch production on this step to continuous
Conti. production process will be integrated in existing batch equipment at minor cost
7 | Oct. 4, 2010
For the above shown reactions Microreactors would be ideal reactors because of
• plug flow
• mixing power
• heat exchange
• low consumption of starting materials in development
Successful Examples in Flow Lab:Transforming reactions into production scale
8 | Oct. 4, 2010
1
10
100
1000
10000
100000
20*10-6 .... 0.4Microreactor 0.1
Stirred Vessel 6000 Stirred Vessel
Mixing power[ W / L]
Reactor Volume [Liter]
Ranges of Mixing Power
1
10
100
1000
10000
100000
20*10-6 .... 0.4Microreactor 0.1
Stirred Vessel 6000 Stirred Vessel
Heat transfer [ W / L K]
Reactor Volume [Liter]
Ranges of Heat Transfer
0
200000
400000
600000
800000
1000000
1200000
0 2000 4000 6000
Cost [CHF]
Volume of Reactor [ L ]
Stirred vessel
Reaction Column
Microreactors (Volumes 90 ...360 ml)
Limitations of microreactors
• Microreactor costs at reaction times > 2 .. 10 min get highIn many cases the reactions in our portfolio cannot be shortened below 2..10min selectivity issue at higher temperatures
Is CM limited to short reactions?
There are cost efficient solutions for longer reaction times
Successful Examples in Flow Lab:Transforming reactions into production scale
9 | Oct. 4, 2010
RCl
R'R
R'
R' R
R'
R'
+Cat.
Product Byproduct
Side Reaction
+
Sonogashira Coupling Reaction
Reaction time of Sonogashira Coupling Step reduced from 7h to 1 h for continuous processing
Highly exothermic reaction (adiabatic heat increase 164 °C), possible heat accumulation in batch reactor in case of inactive catalyst
Situation at project start: large production capacity >100 t/a expected
Identical selectivity in continuous mode, safe reaction conditions, economic equipment possible compared to batch manufacturing?
Transforming reactions into production scaleExample Pd- catalyzed Reaction
Terbinafin
10 | Oct. 4, 2010
Pd-Cat.
CuCl
0
1
2
3
4
5
6
7
1 10
N/S
= (
1/S
e)
[ -
]
S [ - ]
Reactor variant:
1 Microreactor and
4 static mixer reactors in series
• Simulation of reaction
• Selection of optimal reactor design
based on Semenov number
0.00
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
59.3
59.8
60.3
60.8
61.3
61.8
0 20 40 60 80 100 120
Co
nve
rsio
n
[ -
]
Tem
pe
ratu
re [
°C ]
Reactor Volume [mL]
MicroreactorReaction in 3 plates
Temperature / °C
Wall Temperature / °C
(T in pre-heating / °C)
conversion [ - ]
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
0
10
20
30
40
50
60
70
80
90
100
0 2000 4000 6000 8000 10000 12000 14000
Co
nve
rsio
n
[ -
]
Tem
pe
ratu
re [
°C
]
Reactor Volume [ mL ]
Static Mixer Reactor4 Moduls of different type/size
Temperature / °C
Wall Temperature / °C
Conversion / -
0.0
0.5
1.0
1.5
2.0
2.5
0
20
40
60
80
100
120
140
0 2000 4000 6000 8000
Co
nve
rsio
n
[ -
]
Tem
pe
ratu
re [
°C
]Reactor Volume / mL
Fluitec
Temperature / °C
Wall Temperature / °C
Conversion / -
Transforming reactions into production scale Flow Reactors for longer reaction times
11 | Oct. 4, 2010
Static Mixer Reactor
2 Moduls of different type/size
.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
40
50
60
70
80
90
100
110
120
130
140
0 5 10 15 20 25
Yie
ld
Te
mp
era
ture
[°
C]
Stirred Chambers
Simulation Pilotplant (two temperature levels)
Temperature / [°C]
Jacket temperature / [°C]
Yield
Maximum yield of 95.3 %
Reactor variant: Reaction Column
Typical reaction times 0.5<tr<2 h
Small reaction volumes in conti. mode
Large production capacity
First simulations showed lower yield
in reaction column: 91 %
compared to batch: 96 %
Lower yield in Reaction Column
results from
- High conversion rate at reactor entrance
- Strong temperature increase
- Increased byproduct formation
Limit the reaction rate in the first reaction chambers
Introduce 2 temperature levels along the column
Max. yield in reaction column: 95.3%
Simulation confirmed in lab and pilot experiments
12 | Oct. 4, 2010
Transforming reactions into production scale Flow Reactors for longer reaction times
• Sonogashira Step combined with precedent reaction step to a 2 step conti. process
• Solvents in both synthesis steps identical to avoid solvent switch between the steps
• No solid handling, no crystallization in conti. process chain
• Process piloted and basic engineering done
Continuous process reduces plant costs by 25% compared to new batch plant
Continuous production process for Sonogashira Coupling Reaction
• Work up steps focused
on conti. extraction and conti. destillation
13 | Oct. 4, 2010
Transforming reactions into production scale Continuous Manufacturing Process for Terbinafin
M
Educts
O2 /
N2
Water
Cyclohexane
to
recovery
Raw
Product
HCl
waste
Reaction Column Static Mixer Extraction
Column
Mixer Settler Falling Film
Destillation Unit
Waste Gas
Current state: 2..3 chemical steps in continuous mode are possible in API synthesis
Yield improvement is possible for selected reaction steps by continuous manufacturing. Huge economic benefits can be achieved
Continuous plant equipment can be 25% cheaper than corresponding batch equipment
• Reaction times have to be relatively short (e.g. <2 hours), work up steps have to be adapted to continuous, expensive solid handling has to be avoided
Conclusions from experiments and experience for Continuous API Processing
14 | Oct. 4, 2010
Economic impact of continuous manufacturing of full API
syntheses was investigated in 3 case studies in Novartis
Total continuous API syntheses (upstream) were
combined with galenical production processes
(downstream)
Short summary on selected aspects with an emphasis on
upstream
Case study on economic impact of CM
15 | Oct. 4, 2010
• Step 1: Design of a conti. process starting from batch process
without experimental verification, Process Flow Diagram,
Material Balance
Step 2: Equipment sizing
• Step 3: Estimation of equipment cost
• Step 4: Estimation of raw material cost
• Step 5: Total capital costs, Operational costs
• Step 8: Total production costs (TPC)
• Step 9: Study on parameter sensitivity
Case study: applied approach in the study
16 | Oct. 4, 2010
: reaction steps
Case study: PFD of 3 conti.steps of the selected 6-step-synthesis
17 | Oct. 4, 2010
0
50
100
150
200
250
Conti. Process with Extrusion
Batch Process with Extrusion
Total Capital
Cost[CHF/kg]
Upstream
Downstream
Equipment Costs CalculationTotal Equipment Costs = Sum of costs of equipment in final size + additional costs (Erection, Piping,
Automation, Engineering) + building related costs
Assumptions: 100 Tons / year DS, 335 working days / year
Capital Costs of Batch and CM Plant for selected 6-step-synthesis
18 | Oct. 4, 2010
Capital Costs for Upstream Plant 53% lower than batch
0
100
200
300
400
500
600
Conti. Process with Extrusion
Batch Process with Extrusion
Total cost[CHF/kg]
Total Production CostTotal Operating Cost
Total Capital Cost
0
5
10
15
20
25
30
35
40
Conti. Process with Extrusion
Batch Process with Extrusion
Operating Cost
[CHF/kg]
Upstream Downstream
Operating Costs- costs for raw materials, utilities, labor
-Number of operators reduced by 50%
Operating Costs for Upstream reduced
by 15% compared to batch
Total Production Costs
TPC reduced by 25% for combined
upstream & downstream CM process
TPC reduced by 23% in upstream
manufacturing
Operating Costs and Total Production Costsof selected 6 step synthesis
19 | Oct. 4, 2010
13.0%
18.5%
23.6%
28.2%
32.4%
36.3%
39.9%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
45.0%
50% 75% 100% 125% 150% 175% 200%
Fra
cti
on
of
Lab
or
Co
st
in T
PC
Fraction of Labor Requirement
Base Case
Base case labor requirement:
10 full time workers per shift
= 50% of batch operation
Fraction of Labor in TPC depends
significantly on Labor Requirement
Opportunity for Continuous Manufacturing
Sensitivity Study: Impact of Labor on Total Production Cost
20 | Oct. 4, 2010
Motivation:
• Batch Plants are used in manufacturing
for more than one API/Drug.
• Difference in flexibility between batch and
continuous manufacturing schemes
Cost benefits of Multipurpose Plant:
• Capital cost divided between products
• Economies of scale
Downside:
• Storage cost for API/Drug
• Setup and cleaning operations adding to
operation cost
1 year
Num
ber
of P
roducts
per
Lin
e
1
2
3
4
5
Pla
nt S
ize
Sensitivity Study: Impact of Multipurpose vs. Dedicated Operation of Manufacturing Plants
21 | Oct. 4, 2010
717
504430
392 368
1192
777
631555
508
0
200
400
600
800
1000
1200
1400
1 2 3 4 5
Number of P roduc ts per L ine
TP
C (
CH
F/k
g)
C ontinuous
B atc hTPC per kg of Product
• CM has lower TPC for each
of the schemes
• TPC decreases for
multipurpose plants
• If CM is run in dedicated and
Batch is run in multipurpose
equipment Batch is cheaper
Sensitivity Study: Impact of Multipurpose vs. Dedicated Operation of Manufacturing Plant
22 | Oct. 4, 2010
Case studies on combined API/DP continuous manufacturing show TPC
reduction up to 25 % in continuous compared to batch manufacturing
Continuous Plants result in lower production costs (TPC) compared to batch Identical flexibility has to be achieved in conti. mode compared to batch mode
Concepts for flexible multipurpose plants should be worked out.
Operation Costs are dominated by raw material cost in upstream optimal synthesis regarding raw material cost and work up steps is key
yield is key
Capital cost and personnel cost are important and can be reduced by CM
Equipment will be dominated in number and cost by work up equipment Efficiency and cost of purification processes are important
Case study on economic impact of CM was based on assumptions which
have to be further proven
Conclusions from Case Study
23 | Oct. 4, 2010
Vision of Novartis and MIT to transform the current batch manufacturing of its drug substances and drug products to a fully continuous sequence of process steps for each drug substance and drug product
New and enabling technologies will be developed within 10 years with significant economic advantages compared to batch manufacturing
Novartis / MIT Center for Continuous Manufacturing
24 | Oct. 4, 2010
Prof. T. Roeder, Dr. J. Hollmann, Dr. G. Paredes, Dr. F.
Kollmer, M. Rentsch, Dr. L. Padeste, M. Aubry, Dr. H.
Hirt, Dr.C. Fleury. U. Scholer, D. Plaziat, Dr. G. Penn,
Dr. U. Beutler, Dr. B. Wietfeld, S. Bourne, Dr. B. Martin
All external partners in numerous co-operations
Students of MIT Practice School Programs Feb, June
2008, Prof. C. Lupis
Novartis/MIT CM Team
Acknowledgements
25 | Oct. 4, 2010